| Progenics Pharmaceuticals Inc. (PGNX) | |||
|---|---|---|---|
| 0 (0%) | 05-05 16:13 | ||
| Open: | Pre. Close: | ||
| High: | Low: | ||
| Volume: | 0 | Market Cap: | 0(M) |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 5.04 One year: 5.64 |
| Support: | Support1: 3.48 Support2: 2.90 |
| Resistance: | Resistance1: 4.31 Resistance2: 4.83 |
| Pivot: | 4.35 |
| Moving Averages: | MA(5): 4.31  MA(20): 4.30 MA(100): 4.03 MA(250): 4.68 |
| MACD: | MACD(12,26): 0.09 Signal(12,26,9): 0.11 |
| %K %D: | %K(14,3): 47.25 %D(3): 50.43 |
| RSI: | RSI(14): 47.86 |
| 52-Week: | High: Low: Change(%): -21.5 |
| Average Vol(K): | 3-Month: 128263 10-Days: 443006 |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 4.797 - 4.821 | 4.821 - 4.841 |
| Low: | 3.962 - 3.984 | 3.984 - 4.002 |
| Close: | 4.067 - 4.102 | 4.102 - 4.131 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.PGNX has closed above bottom band by 20.7%. Bollinger Bands are 33% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Company profile |
|---|
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: | |
| Sector: | |
| Industry: | |
| Shares Out. (M) | 86.60 |
| Shares Float (M) | 68.10 |
| % Held by Insiders | 9.60 |
| % Held by Institutions | 76.10 |
| Shares Short (K) | 5760 |
| Shares Short Prior Month (K) | 5530 |
| Stock Financials | |
|---|---|
| EPS | -0.774 |
| Book Value (p.s.) | 0.350 |
| Profit Margin | -180.28 |
| Operating Margin | -165.87 |
| Return on Assets (ttm) | -29.2 |
| Return on Equity (ttm) | -116.9 |
| Qtrly Rev. Growth | 45.9 |
| Gross Profit (p.s.) | 0.367 |
| Sales Per Share | 0.427 |
| EBITDA (p.s.) | -0.678 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | -63.79 |
| Levered Free Cash Flow (M) | -54.20 |
| Stock Valuation | |
|---|---|
| PE Ratio | -5.30 |
| PEG Ratio | |
| Price to Book value | 11.71 |
| Price to Sales | 9.61 |
| Price to Cash Flow | -5.57 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
